Zogenix responds to Massachussets governor's restriction on Zohydro Zogenix issued a statement regarding Massachussetts governor Patrick's immediate restriction on Zohydro. The company stated, "Zogenix will continue to work to ensure patients suffering from severe chronic pain have access to the FDA-approved medications they need in every state nationwide, including Massachusetts. (...) Zogenix is following a rigorous program required by the FDA to ensure that Zohydro is used safely and responsibly. Zogenix strongly disagrees with the Governor's decision once again to single out Zohydro ER, when the facts show that the risks of abuse with Zohydro ER are no different than those of most other long-acting opioid products on the market today. (...) Zogenix urges the Governor to respect the carefully designed approach imposed by the FDA, and to address the problem of opioid abuse on a class-wide basis."